Description
This work represents the first global effort to standardise care for individuals with achondroplasia (ACH) across the lifespan and specialty areas. In total, 136 consensus statements have been included, each based on available evidence and combined expert experience.
The consensus statements have been developed by 55 international experts from 16 countries and 5 continents. The statements and recommendations were developed using a modified Delphi process, including a face-to-face meeting, and two rounds of voting. Due to the multi-systemic and life-long impact of ACH, it is critical to adopt a multidisciplinary and pro-active approach to clinical and psychosocial care. These statements aim to capture the key challenges and optimal management of ACH across each major life stage and sub-specialty area.
EU-ACH-00374
References:
Savarirayan R, Ireland P, Irving M, Thompson D, Alves I, Baratela WAR, Betts J, Bober MB, Boero S, Briddell J, Campbell J, Campeau PM, Carl-Innig P, Cheung MS, Cobourne M, Cormier-Daire V, Deladure-Molla M, del Pino M, Elphick H, Fano V, Fauroux B, Gibbins J, Groves ML, Hagenäs L, Hannon T, Hoover-Fong J, Kaisermann M, Leiva-Gea A, Llerena J, Mackenzie W, Martin K, Mazzoleni F, McDonnell S, Meazzini MC, Milerad J, Mohnike K, Mortier GR, Offiah A, Ozono K, Phillips III JA, Powell S, Prasad Y, Raggio C, Rosselli P, Rossiter J, Selicorni A, Sessa M, Theroux M, Thomas M, Trespedi L, Tunkel D, Wallis C, Wright M, Yasui N, Fredwall SO Nature Reviews Endocrinology. 2021 Nov 26:1-7.